CARLSBAD, Calif., -- MO BIO Laboratories, Inc., the leader in soil, stool and microbial nucleic acid purification, announces the launch of the PowerFecal™ DNA Isolation Kit. The kit is optimized for isolation of high quality DNA from stool, gut material and biosolids, and provides high quality DNA for use in characterizing the human microbiome. The [...]

Dubai and Woburn, MA USA, -- Courtagen Life Sciences Inc. announced today they have signed an exclusive strategic distribution agreement with the Alliance Global Group (AGBL) to help clinicians in emerging markets diagnose and manage a number of genetically based disorders. Courtagen’s test menu currently offers clinical tests for mitochondrial disorders (mtSEEK™ and nucSEEK™) and [...]

SAN DIEGO, -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced release 6.1 of the Accelrys Materials Studio® modeling and simulation environment, providing seamless integration with the Accelrys Pipeline Pilot scientific authoring application, the scientifically aware Accelrys Enterprise Platform and Accelrys Materials Studio Collection. This newly integrated offering [...]

Marcy l’Etoile (France) and Lexington, MA (U.S.) –— bioMérieux and Quanterix announced today that they have entered into a strategic agreement that gives bioMérieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications. Under the agreement, Quanterix will deliver a new instrument and consumables based on its Simoa technology. bioMérieux [...]

LEXINGTON, Mass. –– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that the University College London (UCL) Cancer Institute has adopted its ThunderStorm™ System as a centralized platform for the validation of genomic and epigenomic targets from clinical and non-clinical studies, including follow-ups for genome-wide and epigenome-wide association studies (GWAS and EWAS), as well [...]

Munich, Germany, – Definiens AG, the leader in image analysis for Digital Pathology, today announced that Dr. Gerald Möller, has joined the company's supervisory board as an independent member and has been appointed chairman. Following the recent financing round, Dr. Möller will guide the expansion of Definiens’ current business and the development and commercialization of [...]

Zurich, Enschede, Paris, -- Micronit, Fluigent, and Zurich Instruments join forces creating the world's first commercial platform for micro electrical impedance spectroscopy Micronit, Fluigent and Zurich Instruments announce today the world's first system solution for micro electrical impedance spectroscopy. The three companies are combining their state-of-the-art products and services in order to provide a novel [...]

Santa Clara, Calif. — Picarro Inc. today announced the appointment of Dr. Subra Sankar as vice president of engineering. Dr. Sankar brings to Picarro more than two decades of engineering and R&D expertise from the life sciences, semiconductor, and high technology instrumentation markets. At Picarro, he will oversee hardware and software engineering as the company [...]

Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has appointed Ron Nersesian Agilent president and chief operating officer, effective immediately. Nersesian has been executive vice president and chief operating officer since November 2011. Nersesian, 53, will continue to be responsible for Agilent's Chemical Analysis (CAG), Life Sciences (LSG), Electronic Measurement (EMG), [...]

DNA2.0, the leading bioengineering solutions provider, today announced a collaboration with the Gene Therapy Program at the Perelman School of Medicine, University of Pennsylvania, to evaluate the impact of gene optimization on in vivo protein expression. DNA2.0’s patented GeneGPS™ technology will be utilized to optimize in vivo protein expression. The research partnership will primarily support [...]